These 10 High-Risk Stocks Are Defying Conventional Wisdom And Charging Higher
High-risk stocks have soared since the March selloff. As the author of today’s article observes, “In essence, most investors on Wall Street are positioning for…
High-risk stocks have soared since the March selloff. As the author of today’s article observes, “In essence, most investors on Wall Street are positioning for…
“If you are looking to hit a home run in the stock market, the NASDAQ Composite is a good place to start,” advises the author…
The two small-cap biotech stocks highlighted in today’s article appear poised to dominate this year and beyond. Why? As the author explains, “Both companies are…
The stock market could be in for an especially volatile time this week and into July – and while the acceleration in new coronavirus cases…
“This pandemic-driven frenzy for drugmaker stocks has made it awfully hard for investors who like to focus on the fundamentals,” notes the author of today’s…
“Against this backdrop, investors will need to crunch the numbers, to find the stocks that are best positioned for current conditions,” advises the author of…
Could a COVID-19 vaccine – or vaccines – be approved before the November election? That’s the bold prediction being made by Jefferies – and if…
In the cancer treatment space, today’s article highlights two small-cap biotech names to consider this month based on their attractive prices and potential to “take…
Recently, many bankrupt and near-bankrupt companies have experienced large price increases. What’s behind this seemingly very irrational trading behavior? The author of today’s article outlines…
“The challenge for investors who are looking to cash in on the hype surrounding a Covid-19 vaccine is placing their bets on the right horse,”…